Artificial Organs Market Size, Share, and Growth Analysis

Global Artificial Organs Market

Artificial Organs Market By Organ Type (Artificial kidney, Artificial liver), By Fixation (Implantable, Wearable), By End-User (Hospitals, Academic and Research Institutes), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35H2303 | Region: Global | Published Date: November, 2024
Pages: 182 |Tables: 97 |Figures: 76

Format - word format excel data power point presentation

Artificial Organs Market Insights

Global Artificial Organs Market size was valued at USD 28.5 billion in 2023 and is poised to grow from USD 30.75 billion in 2024 to USD 56.5 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The increasing number of elderly people worldwide is making organ transplantation especially important. The number of people over 65 years of age receiving and seeking organ transplants is increasing. The demand for prosthetic devices is higher in the elderly population, as they are more susceptible to post-implantation side effects. According to HRSA, 8,895 organ transplant procedures were performed on people over the age of 65 in the US. in 2022. 42,887 organ transplants were performed in the US. in 2022, up from 2021 by 3.7 percent. So, with increasing age increasing demand organ donors increase the need for prosthetic devices.

Transplant waiting lists are expected to grow in the coming years as more patients need transplants, according to a new study. In March 2023, HRSA announced the OPTN Modernization Initiative aimed at improving system quality, accountability and efficiency by updating OPTN technology, data transparency and analytics, governance, management, improvements which will occur on quality and innovation.

Advances in 3D bioprinting in organ transplantation have proven to be important because they are used to create artificial organs. 3D bioprinting is very popular because it reduces the risk of organ rejection. Moreover, artificial intelligence is poised to revolutionize the global trends in manufacturing technology. Currently, many countries are focusing on developing a tool that provides customized organ and donor assessment. This tool will greatly help in effective decision-making regarding organ recovery and will also help patients decide whether to accept a donor organ or wait for better options.

Market snapshot - 2025-2032

Global Market Size

USD 28.5 billion

Largest Segment

Artificial Organs

Fastest Growth

Artificial Bionics

Growth Rate

7.9% CAGR

Global Artificial Organs Market $ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Artificial Organs Market Segments Analysis

Global Artificial Organs Market is segmented by Organ Type, Fixation, End-User and region. Based on Organ Type, the market is segmented into Artificial kidney, Artificial liver, Artificial lungs, Artificial pancreas, Artificial heart and Other organ types. Based on Fixation, the market is segmented into Implantable and Wearable. Based on End-User, the market is segmented into Hospitals, Academic and Research Institutes and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Analysis by Technology

The mechanical segment dominated the market with the highest revenue growth of 66.9% in 2022. This is due to higher organ failure and lower cost of mechanical bionics. Mechanical heart valve durability is significant when compared to other methods, resulting in strong demand. Other factors driving the growth include faster FDA approvals and reimbursement arrangements. For example, in September 2021, the FDA approved the Abbott Portico a FlexNav TAVR system for the treatment of individuals with symptomatic and diseased aortic stenosis who may be at high or very high risk for open heart surgery.

The electronics segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. According to Bionics Queensland, there are approximately 1.0 billion people with physical disabilities, and 190 million adults with major functional challenges. In most developing countries, infrastructure and financial constraints remain high. For many people with disabilities, the only option is to receive prosthetic limbs. These exercisers are myoelectrically controlled battery-electronic systems and can stimulate muscles through sensors. These sensory electronics allow prosthetics to move. Machine learning, smart wearables and element modelling are being used to make progress. Also, increasing accidents, amputees and increasing number of limbless people are expected to drive the demand for electronic bionics.

Analysis by Product

The artificial organs segment dominated the market with a high revenue growth of 70.4% in 2022. The demand for kidney, heart, lung and liver transplants contributes to the average growth of this segment waiting for a kidney transplant in the US. is 5 years. Many factors are considered while on the waiting list, including body size, blood type, donor distance, and disease severity. Thus, the challenge of meeting unmet demand is forcing manufacturers to develop wearable bio-lungs, artificial pancreas and artificial kidneys. Artificial organs include devices such as artificial hearts, kidneys, livers, intestines, and lungs that replace or complement natural organs. This category is important because of organ failure due to chronic diseases, due to injuries or age-related circumstances. These are among the most important contributors to the kidney prosthesis stage. For example, SynCardia Systems' Total Artificial Heart provides a life-saving solution for patients waiting for a heart transplant.

The artificial bionics segment is expected to grow at the fastest CAGR of 10.7% during the forecast period from 2024 to 2031. The major factors contributing to the growth of the segment are increasing demand for cochlear implants, vision, exoskeleton, limb, brain bionics fueling the market growth for prosthetics and bionics. For example, in January 2022, Cochlear Limited's cochlear nucleus implants received approval from the US. the Food and Drug Administration to treat unilateral hearing loss and unilateral deafness. Artificial bionics refers to advanced bionic devices that not only recreate the physical structure of human organs or body parts but also enhance the sensitivity or function of those organs. This segment targets individuals in need of a prosthetic device that performs well, allowing for greater mobility and quality of life.

Global Artificial Organs Market By Product (%)

To get detailed analysis on other segments, Request For Free Sample Report

Artificial Organs Market Regional Insights

North America ruled the marketplace, accounting for the largest sales share at 45.0% in 2022. This growth is attributed to the rise in transplant surgical operations. Major biotechnology and medical device manufacturers within the place, which include Zimmer Biomet, Arthrex, Inc., Medtronic, Novartis AG, and Stryker, make contributions to this dominance. For example, in March 2022, Zimmer Biomet Holdings, Inc. become acquired. By means of the business enterprise announced WalkAI, a growing AI gadget that identifies patients. The wide variety of donors within the US. Has increased dramatically over the last 5 years.

Asia Pacific is anticipated to witness quickest increase at a CAGR of 11.1% for the duration of the forecast period from 2024 to 2031, driven by way of the emerging economies consisting of Japan, China and India. Chronic diseases leading to the high rates of organ failure are expected to fuel the growth of prosthetic organs and motor devices. In January 2022, Warburg Pincus invested $210 million in Micro Life Sciences Pvt Ltd, the parent organization of Indian medical device company Merrill. The investment will promote domestic high quality regulatory medical devices in a global context, expanding their overseas footprint, attracting international talent, scaling up clinical research programs and potentially. The countries are technologically advanced and offer advanced surgeries with medical tourism growing.

Global Artificial Organs Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Artificial Organs Market Dynamics

Artificial Organs Market Drivers

Increasing Prevalence of Chronic Diseases

  • Increasing incidence of chronic diseases such as kidney failure, heart disease and liver disease is a major driver of the artificial organs market. While many patients are suffering from organ dysfunction the demand for prosthetic organs such as dialysis machines, artificial hearts and liver support systems continues to rise. This increased demand for an ageing population, poor quality of life has more fuel, creating a greater need for the life-saving exercises.

Advances in Medical Technology

  • Continued innovations in medical technology including 3D printing, tissue engineering, and biomaterials are leading to more advanced prosthetics. These technological advances enable more advanced prostheses that are naturally a live encounter that closely mimic the function of real human organs, thereby improving the patient outcomes. The potential applications of prosthetics in healthcare are expanding.

Artificial Organs Market Restraints

High Cost of Prosthetics and Surgery

  • Despite technological advancements, the high cost of prosthetics and related medical procedures remains a major barrier to the market growth. The high cost of research, development and manufacturing of these devices puts them out of reach for most of the world population, especially in the developing areas. This limits the use of prosthetics in patients without limited income or adequate health care.

Risk of Complications and Rejection

  • Potential complications such as infection, mechanical failure, and the immune rejection of prostheses are an important preventive measure. Although biocompatible materials and improved surgical techniques have reduced these risks, complications remain a concern. Such risks not only affect patient safety but also raise legal challenges, limiting the widespread use of prosthetics.

Request Free Customization of this report to help us to meet your business objectives.

Artificial Organs Market Competitive Landscape

The Artificial Organs Market is highly competitive, driven by technological innovation and the growing availability of organ replacements. Key players in the market are working to address the gap between increasing organ failure rates, donor availability and transplant needs. Leading companies such as Abbott Laboratories, Medtronic, Zimmer Biomet, Syncardia Systems, Cochlear Ltd. dominate the market with advanced solutions for heart, kidney, liver and cochlear implants. These companies invest heavily in R&D to improve patient outcomes. For example, through innovations in artificial heart and pancreas solutions, as well as strategic acquisitions of subsidiaries, Medtronic has expanded its product portfolio and market presence. Collaboration between leading companies and research institutes accelerates innovation. Strategic partnerships help companies develop next-generation prosthetic limbs, incorporating cutting-edge technologies such as 3D printing and biocompatible materials to drive performance and longevity high.

Top Player's Company Profiles

  • Berlin Heart 
  • Abbott 
  • Boston Scientific 
  • Cochlear 
  • Edwards Lifesciences 
  • Ekso Bionics 
  • Jarvik Heart 
  • Medtronic 
  • SynCardia Systems 
  • Zimmer Biomet 
  • Wearable Artificial Organs, Inc 
  • CARMAT 
  • BiVACOR Inc. 
  • TransMedics 
  • Fresenius Medical Care

Recent Developments in Artificial Organs Market

  • In February 2022, Vanderbilt University Medical Center, Carnegie Mellon University and Cornell University received a four-year, $87 million Congressionally Directed Medical Research Program (CDMRP) grant from the Department of Defense to build an artificial lung platform.
  • In February 2022, the School of Medical Research and Technology (SMRT), IIT Kanpur, launched Hridayantra, a large complexity-based program to develop an artificial heart or an advanced left ventricular assist device.
  • In February 2023, SynCardia Systems, LLC received FDA clearance to update the portable driver software for its existing artificial hearts. The Freedom Driver is designed to be used with the company’s complete artificial heart in the medically complex patient population.
  • In December 2022, Carmat issued $33.6 million in cash through a dividend. The company intends to use the funds raised through this global offering to support research and development activities, increase production and relaunch sales of the company’s products.

Artificial Organs Key Market Trends

Artificial Organs Market SkyQuest Analysis

SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to SkyQuest analysis, the increasing incidence of chronic diseases and advances in medicine have led to a greater demand for life-saving solutions. But the market faces challenges due to high cost of prosthetics, challenges and potential risks associated with rejection. Major trends such as the integration of 3D printing with the rise of bioengineered organs plans to restructure the industry, making prosthetics more accessible and effective and continues innovation and increasing investment in research, artificial organs market has great potential for growth in the coming years.

Report Metric Details
Market size value in 2023 USD 28.5 billion
Market size value in 2032 USD 56.5 billion
Growth Rate 7.9%
Base year 2024
Forecast period 2025-2032
Forecast Unit (Value) USD Billion
Segments covered
  • Organ Type
    • Artificial kidney
    • Artificial liver
    • Artificial lungs
    • Artificial pancreas
    • Artificial heart
    • Other organ types
  • Fixation
    • Implantable
    • Wearable
  • End-User
    • Hospitals
    • Academic and Research Institutes
    • Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Berlin Heart 
  • Abbott 
  • Boston Scientific 
  • Cochlear 
  • Edwards Lifesciences 
  • Ekso Bionics 
  • Jarvik Heart 
  • Medtronic 
  • SynCardia Systems 
  • Zimmer Biomet 
  • Wearable Artificial Organs, Inc 
  • CARMAT 
  • BiVACOR Inc. 
  • TransMedics 
  • Fresenius Medical Care
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Artificial Organs Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Artificial Organs Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Artificial Organs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Artificial Organs Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Artificial Organs Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Artificial Organs Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Artificial Organs Market size was valued at USD 47.83 Billion in 2023 and is poised to grow from USD 51.5 Billion in 2024 to USD 93.1 Billion by 2032, growing at a CAGR of 7.68% during the forecast period (2025-2032).

The Artificial Organs Market is highly competitive, driven by technological innovation and the growing availability of organ replacements. Key players in the market are working to address the gap between increasing organ failure rates, donor availability and transplant needs. Leading companies such as Abbott Laboratories, Medtronic, Zimmer Biomet, Syncardia Systems, Cochlear Ltd. dominate the market with advanced solutions for heart, kidney, liver and cochlear implants. These companies invest heavily in R&D to improve patient outcomes. For example, through innovations in artificial heart and pancreas solutions, as well as strategic acquisitions of subsidiaries, Medtronic has expanded its product portfolio and market presence. Collaboration between leading companies and research institutes accelerates innovation. Strategic partnerships help companies develop next-generation prosthetic limbs, incorporating cutting-edge technologies such as 3D printing and biocompatible materials to drive performance and longevity high. 'Edwards Lifesciences Corporation ', 'Cochlear Limited ', 'Zimmer Biomet Holding Inc. ', 'Jarvik Heart, Inc. ', 'Boston Scientific Corporation ', 'Berlin Heart GmbH ', 'SynCardia Systems LLC ', 'CARMAT ', 'BiVACOR Inc. ', 'AWAK Technologies ', 'Wearable Artificial Organs, Inc. ', 'Medtronic Plc ', 'ALung Technologies, Inc. ', 'Fresenius Medical Care ', 'Johnson & Johnson ', 'TransMedics, Inc ', 'Abott'

Increasing incidence of chronic diseases such as kidney failure, heart disease and liver disease is a major driver of the artificial organs market. While many patients are suffering from organ dysfunction the demand for prosthetic organs such as dialysis machines, artificial hearts and liver support systems continues to rise. This increased demand for an ageing population, poor quality of life has more fuel, creating a greater need for the life-saving exercises.

Integration of 3D Printing in Prosthetics: 3D printing is revolutionizing the artificial organs market by enabling customized, patient-specific organs. This technology improves the accuracy, functionality and biocompatibility of complex organ systems. In addition, 3D printing can reduce prosthesis costs and shorten manufacturing time, making this technology a growing market segment.

North America ruled the marketplace, accounting for the largest sales share at 45.0% in 2022. This growth is attributed to the rise in transplant surgical operations. Major biotechnology and medical device manufacturers within the place, which include Zimmer Biomet, Arthrex, Inc., Medtronic, Novartis AG, and Stryker, make contributions to this dominance. For example, in March 2022, Zimmer Biomet Holdings, Inc. become acquired. By means of the business enterprise announced WalkAI, a growing AI gadget that identifies patients. The wide variety of donors within the US. Has increased dramatically over the last 5 years. Asia Pacific is anticipated to witness quickest increase at a CAGR of 11.1% for the duration of the forecast period from 2024 to 2031, driven by way of the emerging economies consisting of Japan, China and India. Chronic diseases leading to the high rates of organ failure are expected to fuel the growth of prosthetic organs and motor devices. In January 2022, Warburg Pincus invested $210 million in Micro Life Sciences Pvt Ltd, the parent organization of Indian medical device company Merrill. The investment will promote domestic high quality regulatory medical devices in a global context, expanding their overseas footprint, attracting international talent, scaling up clinical research programs and potentially. The countries are technologically advanced and offer advanced surgeries with medical tourism growing.

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Feedback From Our Clients

Global Artificial Organs Market
Artificial Organs Market

Report ID: SQMIG35H2303

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE